GENEVA, May 17 -- ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room 1106, Building 1, Haozhang Plaza, Gongshu DistrictHangzhou, Zhejiang 310015), 浙江扬厉医药技术有限公司 (中国浙江省杭州市拱墅区皓章大厦1 幢1106 室) filed a patent application (PCT/CN2024/130518) for "DOUBLE-STRANDED SIRNA FOR INHIBITING PNPLA3 EXPRESSION AND CONJUGATE COMPRISING SAME" on Nov 07, 2024. With publication no. WO/2025/098440, the details related to the patent application was published on May 15, 2025.
Notably, the patent application was submitted under the International Patent Classi...